ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

September 4, 1998